The North American cardiology market is estimated to grow significantly at a CAGR of 6.2% during the forecast period. North America’s cardiology market is projected to grow due to the highest consumption of cardiology devices and surgeries. In the US alone, 0.6 million people lose their life due to heart diseases, according to WHO the incidence & prevalence rate of heart attack are the highest in North America which is responsible for 0.7 million fatalities each year. According to the Heart & Stroke foundation in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease.
To Request a Sample of our Report on North American Cardiology Market: https://www.omrglobal.com/request-sample/north-american-cardiology-market
The market is segmented on the basis of device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, Cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.
(Get 15% Discount on Buying this Report)
A full Report of North American Cardiology Market is Available at: https://www.omrglobal.com/industry-reports/north-american-cardiology-market
North American Cardiology Market Segmentation
By Device Type
· Angioplasty
· Cardiovascular stents
· Cardiovascular catheters
· Cardiac rhythm management
· Cardiovascular assistive devices
By Drug Type
· Antithrombotic drugs
· Antidyslipidemic drugs
· Antihypertensive drugs
· Anti-stroke drugs
By Drug Type
· Beta blockers
· Beta agonists
· Alpha blockers
· Alpha agonists
· Sodium channel blockers
· Calcium channel blockers
· Vasodilators
· Renin inhibitors
· Angiotensin receptor blockers
· Diuretics
· Thrombolytics
By Drug Type
· Coronary artery bypass grafting
· Transmyocardial laser revascularization
· Heart valve repair
· Arrhythmia treatment
· Aneurysm repair
· Heart transplant
Regional Analysis
· United States
· Canada
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
